Cardiologs Technologies

Company profile

About Cardiologs Technologies

Cardiologs Technologies is a pioneering AI-powered cardiac diagnostics company that has been integrated into Philips Healthcare. The company develops medical-grade artificial intelligence solutions for electrocardiogram (ECG) analysis, specifically targeting the detection and diagnosis of cardiac arrhythmias. Cardiologs made history as the first AI solution approved by the FDA for ECG analysis in 2017. The company's flagship product, the Cardiologs Holter platform, uses deep neural network (DNN) technology and cloud-based infrastructure to analyze continuous ambulatory ECG recordings. Built upon a foundation of over 200 million ECG recordings, the AI engine analyzes ECG waveforms holistically, mimicking human brain function to handle complex cardiac patterns more effectively than traditional rule-based algorithms. The platform can detect more than 20 types of cardiac events, including atrial fibrillation, ventricular tachycardia, various types of heart blocks, and premature complexes. Cardiologs serves healthcare providers and cardiac diagnostic service organizations globally, with their AI technology used across five continents to diagnose over 2 million patients annually. The company has demonstrated significant clinical impact, including a 42% reduction in Holter analysis time and a 10-fold reduction in atrial fibrillation false positives compared to traditional methods. With over 20 peer-reviewed scientific publications validating their algorithms, Cardiologs continues to advance cardiac care by exploring ECG biomarkers and smartwatch-based cardiac monitoring capabilities.

Company description · Cardiologs Technologies official website